| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.08 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.08 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.09 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.09 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.09 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.09 |